Your browser doesn't support javascript.
[Introduction and implications of WHO position paper: vaccines against influenza, May 2022].
Feng, L Z; Jiang, H Y; Yi, J; Qian, L L; Xu, J D; Zheng, L B; Ma, Z B; Peng, S J; Jiang, S T; Xu, E F; Chen, L H; Wang, L D; Gao, W Z; Yang, Weizhong.
  • Feng LZ; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Jiang HY; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Yi J; Chinese Prevention Medicine Association, Beijing 100021, China.
  • Qian LL; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Xu JD; Institute for Non-communicable Disease Control and Prevention, Qinghai Center for Disease Control and Prevention, Xining 810001, China.
  • Zheng LB; Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Ma ZB; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Peng SJ; Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Jiang ST; Department of Immunization Planning, Nanshan District Center for Disease Control and Prevention, Shenzhen 518055, China.
  • Xu EF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Chen LH; Zhejiang Center for Disease Control and Prevention, Hangzhou 310051, China.
  • Wang LD; Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Gao WZ; Hunan Center for Disease Control and Prevention, Changsha 410005, China.
  • Yang W; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Zhonghua Yi Xue Za Zhi ; 102(30): 2315-2318, 2022 Aug 16.
Article in Chinese | MEDLINE | ID: covidwho-1994236
ABSTRACT
On May 13, 2022, World Health Organization(WHO) Position Paper on Influenza Vaccine (2022 edition) was published. This position paper updates information on influenza epidemiology, high risk population, the impact of immunization on disease, influenza vaccines and effectiveness and safety, and propose WHO's position and recommendation that all countries should consider implementing seasonal influenza vaccine immunization programmes to prepare for an influenza pandemic. In addition, it proposes that the influenza surveillance platform can be integrated with the surveillance of other respiratory viruses, such as SARS-CoV-2 and Respiratory Syncytial Virus. This position paper has some implications for the prevention and control of influenza and other respiratory infectious diseases in China (1) Optimize influenza vaccine policies to facilitate the implementation of immunization services; (2) Influenza prevention and control should from the perspective of Population Medicine focus on the individual and community to integrate with "Promotion, Prevention, Diagnosis, Control, Treatment, Rehabilitation"; (3) Incorporate prevention and control of other respiratory infectious diseases such as influenza, COVID-19, respiratory syncytial virus and adenovirus, and intelligently monitor by integrating multi-channel data to achieve the goal of co-prevention and control of multiple diseases.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: Chinese Journal: Zhonghua Yi Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112137-20220518-01090

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: Chinese Journal: Zhonghua Yi Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112137-20220518-01090